Conditions: Schizophrenia
Keywords: Schizophrenia Latuda Lurasidone
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 61
Healthy volunteers: no

Brief summary:
A 1-year outpatient study to test the safety and tolerability of a new medication in the treatment of schizophrenia

Detailed description:
Study will evaluate long-term safety and tolerability of a new compound in the treatment of patients with schizophrenia as assessed by adverse events (AEs), measures of extra pyramidal symptoms (EPS; Abnormal Involuntary Movement Scale \[AIMS\], Barnes Akathisia Scale \[BAS\], and Simpson-Angus Rating Scale \[SAS\]), vital sign measurements, electrocardiograms (ECGs), clinical laboratory evaluations.

Arms:
arm 1: Lurasidone 80mg oral tablet taken once a day

Interventions: intervention 1: Lurasidone 80mg tablet
Intervention descriptions: intervention 1: None

Protocol document: